CYP2C19
Genetic Testing Should Not Be Done in All Patients Treated With Clopidogrel Who Are Undergoing Percutaneous Coronary Intervention
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- October 2011
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- 1103 Clinical Sciences (FoR)
- 1117 Public Health and Health Services (FoR)
- Aryl Hydrocarbon Hydroxylases (MeSH)
- Biomarkers, Pharmacological (MeSH)
- Cardiovascular System & Hematology (Science Metrix)
- Clopidogrel (MeSH)
- Cytochrome P-450 CYP2C19 (MeSH)
- Genetic Testing (MeSH)
- Humans (MeSH)
- Platelet Aggregation Inhibitors (MeSH)
- Ticlopidine (MeSH)